CHI: 8th Annual Immuno-Oncology Virtual Summit 2020 | October 6th - 8th, 2020
Something great is coming up! Join us at "Preclinical and Translational Immuno-Oncology", part of CHI's Immuno-Oncology Summit. Dr. Christoph Sachse will give a talk "Efficacy Testing and Mechanistic Studies in Patient-Derived Microtumor/Immune Cell Models" on October 7th at 11.20 EST - we are looking forward to the talk and the following discussion! Feel invited to additionally contact us: email@example.com.
ELRIG: Drug Discovery Digital 2020 | October 6th - 16th, 2020
We are looking forward to share our scientific data with you at the ELRIG Drug Discovery Digital 2020 conference. You can find us at the poster nr. 24: "‘Beyond Genomics’ in Precision Oncology: A Multiplex Pathway Activity Profiling Platform for Tumor and Organoid Samples".
AACR: Virtual Annual Meeting 2020 | June 22nd & 24th, 2020
We are looking forward to the AACR (American Association for Cancer Research) Virtual Annual Meeting 2020 in June (22-24th). Join us at the poster presentation where we will introduce you to the latest research using our proprietary technology DigiWest. If you should have any questions, do not hesitate to contact us at firstname.lastname@example.org.
EACR: Virtual Cancer Congress | June 18th & 19th, 2020
Oxford Global Conferences: Biomarker Series 2020 | February 18th - 20th, 2020
Dr. Thomas Joos is going to give a talk on Biomarker Series 2020 conference organized by Oxford Global: Technical Validation and Drug Induced Injury Biomarker Qualification. In case you are going to attend the conference, come listen to the talk at 18.10 on Wednesday, February 19th. Questions welcome!
34. Deutscher Krebskongress | February 19th - 22nd, 2020
Coming up: 34. Deutscher Krebskongress! At NMI and NMI TT Pharmaservices, we intensively work on the development of new approaches for cancer research. Focusing on precision medicine and its goal of achieving a better response rate by avoiding ineffective therapies, we are testing patient-derived 3D (PD3Ds) tumor cultures for modeling individual response and using various molecular pathology techniques for advanced tumor profiling (like DigiWest®).
Join us at the poster presentation to learn about our work.
Goodbye Flat Biology | November 10-13, 2019
Soon, we will attend a conference in Berlin - Goodbye Flat Biology: Advancing 3D-based Models fo Cancer Biology and Drug Discovery. Coming over? Join us at the booth, get to know our DigiWest technology, and get familiar with our latest research on patient-derived tumor models. We are excited to welcome you there!
ELRIG Drug Discovery | November 5-6, 2019
We don't know whether or not the UK will still be in the EU at that time, but Ziva Rejc and Christoph Sachse will be in Liverpool in November with our posters, to talk to our British friends and colleagues.
Contact us if you'd like to meet.
And don't miss our talk "Immuno-Oncology Drug Testing in Patient-Derived Microtumor/Immune Cell Models: The Added Value of Protein Profiling"!
xMAP Connect Amsterdam | November 5-6, 2019
We will meet our friends at Luminex in Amsterdam again, as a Gold Sponsor of their xMAP Connect event. Click the picture to register!
NCRI Cancer Conference | November 3-5, 2019
Meet us with our most recent poster at the NCRI Cancer Conference in Glasgow. Contact us to have a chat.
xMAP Connect San Diego | October 3, 2019
Together with our collaborators from CELLphenomics and LI-COR we'll be at the North American edition of xMAP Connect. Hear more about DigiWest from PD3D patient-derived organoids in the presentation given by Christian Regenbrecht.
Safety Pharmacology | September 22-26, 2019
We are heading to Barcelona! Join us at the SPS 2019 conference organized by Safety Pharmacology Society. Visit us at our NMI TT Pharmaservices booth to see what we have prepared for you this time and attend our sponsored presentation: hiPSC for Drug Discovery and Safety Assessment Using Live Kinetic and Electrophysiological Readouts on Wednesday, September 25th at 12.30 in room 121 (find the invitation here). There will be cookies and coffee afterward for the perfect discussion setting.
If you wish to schedule a meeting in advance, leave us a note in our contact form .
We are excited about seeing you there!
Drug Discovery | June 10-12, 2019
This time in Berlin! Leave us a note in our contact form to organize a meeting with us at 20th Annual Drug Discovery Summit Meeting. We are looking forward to seeing you there!
Immuno-Oncology | May 23-24, 2019
We will be at the Immuno-Oncology Meeting held in Barcelona, presenting new data on DigiWest and on our immuno-oncology compound testing services.
ELRIG Cell-Based Screening | May 22-24, 2019
We look forward to ELRIG's Advances in Cell-Based Screening Meeting at AstraZeneca Mölndal, where we will present posters on our immuno-oncology assay platform as well as on DigiWest from FFPE samples.
MIXiii-Biomed | May 14-16, 2019
Another classic. We will attend the renowned Biomed conference in Tel Aviv. Please send us an email if you'd like to talk to us.
Bionnale | May 7, 2019
A great meeting, not far away from our Berlin-based offices: Of course we will attend Bionnale 2019, to catch up with our friends, clients and partners from the Berlin community and beyond.
ELRIG Research & Innovation | April 2-3, 2019
Christoph Sachse will be at ELRIG's Research & Innovation Meeting in Cambridge/UK and present a poster with our most recent DigiWest data from FFPE samples. Please send us a note through the conference app if you'd like to talk to us.
AACR | Mar 29 - Apr 3, 2019
We 're looking forward to #AACR19! Gerrit Erdmann will present a poster on an exciting collaborative effort led by CPO and Helios Klinikum Berlin, involving DigiWest-based phosphoprotein profiling of patient-derived sarcoma cell models. Please contact us if you'd like to meet us in Atlanta!
RPPA Global Workshop | Mar 24-25, 2019
Thomas Joos and Michael Pawlak will present our immunoassay capabilities at the 8th Global RPPA Workshop in Tokyo, Japan.
WPC | Nov 27-30, 2018
We're excited to announce that Dr. Christian Schmees will present our patient-derived 3D microtumor / immune cell assay platform at WPC in Lisbon.
ENA | Nov 13-16, 2018
Dr. Michael Pawlak will take part in the 30th EORTC-NCI-AACR Symposium. He will present a poster with our latest results on RPPA protein profiling of patient-derived 3D microtumor models.
xMAP Connect | Nov 6-7, 2018
As a Luminex partner, we are sponsoring xMAP Connect in Amsterdam, organized by Luminex. Meet Thomas Joos, Markus Templin, and Nicole Schneiderhan-Marra at our booth, and get the most recent updates on DigiWest and on our modified Luminex bead products.
R2N Symposium | Nov 6-7, 2018
Udo Kraushaar is participating at the R2N Symposium in Hannover and will give the talk entitled: Transforming (stem) cell models from academic research to pharma – about assay development and validation.
ESTIV | Oct 15-18, 2018
We offer protein profiling assays for safety and toxicology - please see Christoph Sachse's poster at the 20th International Congress on In Vitro Toxicology (ESTIV) in Berlin.
ELRIG Drug Discovery | Oct 9-10, 2018
London Calling ... Christoph Sachse and Richard Griesbach look forward to meeting you in London at ELRIG's Drug Discovery Meeting. At booth C2 we will highlight our cell-based offerings: customized cell lines, hiPSC models and immuno-oncology testing services. And don't miss Richard's talk on CRISPR cell models.
MipTec | Sep 11-14, 2018
It's MipTec time again! Christoph Sachse will be in Basel to meet our Swiss clients at Basel Life.
Goodbye Flat Biology | Sep 9-12, 2018
We're sponsoring EACR's Goodbye Flat Biology. Meet Simge Yüz and Christoph Sachse at our booth and see our posters on the use of patient-derived 3D cell models for immuno-therapy testing.
Sophion User Meeting | Sep 5-6, 2018
Our electrophysiology experts Timm Danker and Alejandra Bärfuss will be attending the Sophion European User Meeting in Stevenage, UK.
Immuno-Oncology Summit | Aug 27-31, 2018
Christoph Sachse will take part in CHI's Immuno-Oncology Summit in Boston on August 27-31, with a poster on DigiWest and with a talk on our latest results using patient-derived microtumor/immune cell co-cultures.